Dr. Sushama R. Chaphalkar

PhD in Microbiology

Biotechnology, Microbiology

Dr. Sushama R. Chaphalkar is a senior researcher and academician based in Pune, India. She holds a PhD in Microbiology and comes with vast experience in research and education in Biotechnology. In her illustrious career spanning three decades and a half, she held prominent leadership positions in academia and industry. As the Founder-Director of a renowned Biotechnology institute, she worked extensively on high-end research projects of industrial significance, fostering a stronger bond between industry and academia.

Dr. Chaphalkar is passionate about sustainable development through Biotechnology and brought about significant agrarian development in parts of rural Maharashtra, through her 11-year-long project titled “Biovillage,” which involved need-based research as well as training of the rural population, especially farmers. When she is not working or mentoring students, she finds joy in avid reading, music, gardening, culinary adventures, and exploring new destinations through travel.

See less

Articles from Sushama R.

Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.

3 Sep 2024

Long COVID symptom severity varies widely by age, gender, and socioeconomic status

Study analyzes self-reported long COVID symptoms through a healthcare app, revealing that symptom severity significantly varies by demographic factors such as age, gender, race, education, and socioeconomic status.

2 Sep 2024

Research finds particulate pollution during pregnancy may impact newborn kidney function

Research reveals that gestational exposure to air pollution increases cord blood cystatin C levels, indicating potential kidney function issues in newborns.

2 Sep 2024

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

A study published in eClinicalMedicine found that tirzepatide outperforms semaglutide in reducing the risk of type 2 diabetes and major cardiovascular events among individuals with obesity, with or without existing diabetes, while also achieving greater weight loss.

28 Aug 2024

Deep learning reveals disparities in brain aging across Latin America and the Caribbean

Study reveals that socioeconomic inequality, pollution, and health disparities significantly contribute to brain-age gaps, with Latin American and Caribbean populations, especially women and those with cognitive impairments, being most affected.

28 Aug 2024

Should extremely preterm infants be given probiotics?

Researchers found that probiotics similarly impact the gut microbiome in extremely preterm infants as in very preterm infants, suggesting potential benefits for NEC prevention, but further research is needed.

26 Aug 2024

Total neoadjuvant therapy shows promising results in routine care for advanced rectal cancer

Research on a modified TNT regimen for high-risk rectal cancer reveals similar complete response rates and lower toxicity compared to traditional approaches.

26 Aug 2024

Clarification urgently needed for detected signal of semaglutide-linked suicidal ideation

Researchers investigate the potential link between the obesity drugs semaglutide and liraglutide and suicidal or self-injurious adverse drug reactions.

26 Aug 2024

New tool could revolutionize cardiovascular risk management: PRESS score validated

The association between platelet hyperreactivity and the risk of cardiovascular events.

22 Aug 2024

The role of the Mediterranean diet in cardiovascular disease prevention

Researchers perform an updated review of recent studies to evaluate the effectiveness of the Mediterranean Diet in preventing cardiovascular disease.

21 Aug 2024

Dr. Sushama R. Chaphalkar

Articles from Sushama R.

Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

Long COVID symptom severity varies widely by age, gender, and socioeconomic status

Research finds particulate pollution during pregnancy may impact newborn kidney function

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

Deep learning reveals disparities in brain aging across Latin America and the Caribbean

Should extremely preterm infants be given probiotics?

Total neoadjuvant therapy shows promising results in routine care for advanced rectal cancer

Clarification urgently needed for detected signal of semaglutide-linked suicidal ideation

New tool could revolutionize cardiovascular risk management: PRESS score validated

The role of the Mediterranean diet in cardiovascular disease prevention

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Latest News